Allakos Inc
Biotechnology ResearchCalifornia, United States11-50 Employees
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Allakos Inc uses 8 technology products and services including SiteCatalyst, Microsoft Excel, Oracle, and more. Explore Allakos Inc's tech stack below.
| Allakos Inc Email Formats | Percentage |
| FLast@allakos.com | 84% |
| First.Last@allakos.com | 14% |
| FirstLast@allakos.com | 1% |
| LastFirst@allakos.com | 1% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Allakos Inc has raised a total of $150M of funding over 5 rounds. Their latest funding round was raised on Sep 19, 2022 in the amount of $150M.
Allakos Inc's revenue is estimated to be in the range of $10M$25M
Allakos Inc has raised a total of $150M of funding over 5 rounds. Their latest funding round was raised on Sep 19, 2022 in the amount of $150M.
Allakos Inc's revenue is estimated to be in the range of $10M$25M